Recent Finacing
Recent Raise
Biobeat develops the first FDA-cleared, patch-worn, cuff-less 24-hour ambulatory blood pressure monitor for hypertension management.
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at Biobeat.
